bluebird bio (BLUE) PT Lowered to $161 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst John Newman lowered the price target on bluebird bio (NASDAQ: BLUE) to $161.00 (from $250.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
